Search Within

Martin Stuart Tallman

  1. "2015"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (25)
  3. Book Section (1)
Groups
  1. Adult Leukemia (64)
  2. Center for Hematologic Malignancies (64)
  3. Department of Medicine (64)
  4. Hematologic Malignancies, Division of (64)
  5. Executive Committee, Center for Hematologic Malignancies (21)
  6. GSK Faculty (21)

More Groups

People
  1. Ross Levine (18)
  2. Eytan Stein (10)
  3. Omar Abdel-Wahab (8)
  4. Sean Devlin (7)
  5. Dan Douer (6)
  6. Jae Park (6)

More People

Years
  1. 2015 (64)
Publications
  1. Blood (30)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Journal of Clinical Oncology (4)
  4. Haematologica (3)
  5. Leukemia (3)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. Elsevier Inc. (8)
  3. Nature Publishing Group (5)
  4. American Society of Clinical Oncology (4)
  5. Ferrata Storti Foundation (3)
  6. John Wiley & Sons (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytogenetics in hairy cell leukemia at diagnosis and relapse: The rate of therapy-related myeloid malignancies is low
    Meeting Abstract

    Getta, B.; Abdel-Wahab, O.; Park, J. H.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Herpes zoster is more frequent in patients receiving higher cumulative doses of arsenic trioxide and is mitigated by prophylactic acyclovir
    Meeting Abstract

    Glass, J. L.; Kishtagari, A.; Douer, D.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Response to hypomethylating agent therapy in acute myeloid leukemia based upon mutations in the DNA methylation pathway
    Meeting Abstract

    Coombs, C. C.; Devlin, S.; Dixit, S.; Mohanty, A.; Knapp, K. M.; Arcila, M.; Klimek, V. M.; Tallman, M. S.; Levine, R. L.; Rampal, R. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: Results of the dose escalation clinical trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Ofran, Y.; Nagler, A.; Rowe, J. M.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Patient characteristics and early death predictors in acute promyelocytic leukaemia patients; Experience from United Arab Emirates (UAE)
    Meeting Abstract

    Alzaabi, M. R.; Hassan, I. B.; Tallman, M. S.; Alam, A.; Al Qawasmeh, K.; Kristensen, J.
    Blood (2015)

    Fulltext@MSK | Save
  • Expression of an oncogenic ERG isoform characterizes a distinct subtype of B-progenitor acute lymphoblastic leukemia
    Meeting Abstract

    Zhang, J. H.; McCastlain, K.; Qu, C. X.; Wu, G.; Edmonson, M.; Li, Y. J.; Wei, L.; Payne-Turner, D.; Yoshihara, H.; Churchman, M. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A prognostic system predictive of outcomes in persons undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Meeting Abstract

    Shaffer, B. C.; Ahn, K. W.; Hu, Z. H.; Popat, U. R.; Kalaycio, M.; Maziarz, R. T.; Alyea, E.; Sobecks, R. M.; Pavletic, S. Z.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: Results of a phase 1/2 trial
    Meeting Abstract

    Stein, E. M.; DiNardo, C.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Kantarjian, H. M.; Sekeres, M. A.; Fathi, A. T.; Flinn, I. W.; Frankel, A. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind), high-dose C consolidation (consol), and as maintenance (maint) therapy in newly diagnosed acute myeloid leukemia (AML) patients (pts) age 18-60 with FLT3 mutations (muts): An international prospective randomized (rand) P-controlled double-blind trial (CALGB 10603/RATIFY [Alliance])
    Meeting Abstract

    Stone, R. M.; Mandrekar, S.; Sanford, B. L.; Geyer, S.; Bloomfield, C. D.; Dohner, K.; Thiede, C.; Marcucci, G.; Lo-Coco, F.; Klisovic, R. B.; more...
    Blood (2015)

    Fulltext@MSK | Save